Phylogica will provide its Phylomer® libraries to other biotech and pharma companies under a partnership or license agreement.
Phylogica is also offering a number of partnering opportunities to other biotechnology/ pharmaceutical companies seeking; • Agonists or antagonists for drug targets
• Target validation tools for novel pathways or drug targets
Phylogica has refined the process of drug discovery using the Phylomer® libraries and integrating this technology with high throughput screening platforms such as Phage Display and Yeast-two-hybrid. These screening techniques facilitate rapid sampling of the Phylomer® libraries for the structures and shapes that most efficiently bind protein or disrupt specific protein interaction.
